心脏再同步化治疗
医学
降级
相伴的
临床试验
心力衰竭
心脏病学
重症监护医学
内科学
射血分数
计算机安全
计算机科学
作者
Eleni Nakou,Εmmanuel Simantirakis,Eleftherios M. Kallergis,Konstantinos S. Nakos,Panos Vardas
出处
期刊:Europace
[Oxford University Press]
日期:2016-12-05
卷期号:19 (5): 705-711
被引量:7
标识
DOI:10.1093/europace/euw317
摘要
There are limited data about the management of patients presenting for elective generator replacements in the setting of previously implanted cardiac resynchronization therapy (CRT) devices that are nearing end-of-life. The individual patient's clinical status and concomitant morbidities may evolve so that considerations may include not only replacement of the pulse generator, but also potentially changing the type of device [e.g. downgrading CRT-defibrillator (CRT-D) to CRT-pacemaker (CRT-P) or ICD or upgrading of CRT-P to CRT-D]. Moreover, the clinical evidence for CRT-D/CRT-P implantation may change over time, with ongoing research and availability of new trial data. In this review we discuss the ethical, clinical and financial implications related to CRT generator replacements and the need for additional clinical trials to better understand which patients should undergo CRT device downgrading or upgrading at the time of battery depletion.
科研通智能强力驱动
Strongly Powered by AbleSci AI